
zzso cell lung cancer zzso is a leading cause of zzso deaths zzso To improve the prognosis of patients with zzso new and validated therapeutic targets are critically zzso In this study, we focused on zzso and zzso repeat domain zzso zzso an zzso zzso zzso that regulates the degradation of zzso zzso zzso zzso and zzso zzso loss of zzso was associated with increased sensitivity of tumors to a class zzso zzso zzso zzso zzso zzso zzso analysis revealed increased expression of zzso targets, zzso and zzso in zzso tumors with low expression of zzso Moreover, clinical specimens exhibiting low zzso expression presented with more progressive cancer and significantly shorter zzso survival than patients with high zzso zzso zzso study of zzso cell lines with silenced zzso revealed enhanced zzso sensitivity and zzso zzso Interestingly, zzso resistance was eliminated by zzso treatment, suggesting the potential of zzso zzso for the treatment of aggressive zzso zzso that lack zzso 

zzso status impacts zzso and is a zzso marker in zzso zzso zzso zzso 

